13F Filings History of Fan Yu

Latest 13F report
Q4 2025 - 18 Feb 2026
Value $
$92,272,871
Signature - Title
Fan Yu - Self
Location
Central, Hong Kong
Summary
This page shows a list of all the recent 13F filings made by Fan Yu. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Fan Yu reported 5 stock holdings with total value $92,272,871 as of Q4 2025. Top holdings included KMTS, CBLL, ALMS, IVA, and WHWK.

Notify me when Fan Yu files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value

List of Other Managers Reporting for Fan Yu:

Name Holdings Value Location File Number
Ally Bridge Group (NY) LLC $62,997,127 New York, NY 028-20834
ABG Innovation Capital Partners III GP Ltd $64,532 Central, Hong Kong, Hong Kong 028-20837
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 5 $92,272,871 +$6,975,000 -$17,625,536 -$10,650,536 KMTS, CBLL, ALMS, IVA, WHWK 13F-HR 17 Feb 2026, 19:30
Q3 2025 4 $76,864,104 $0 -$3,757,440 -$3,757,440 KMTS, CBLL, WHWK, ALMS 13F-HR 14 Nov 2025, 16:32
Q2 2025 5 $73,186,158 +$2,452,956 -$4,707,896 -$2,254,940 KMTS, CBLL, WHWK, CRGX, ALMS 13F-HR 14 Aug 2025, 16:36
Q1 2025 9 $97,313,288 +$60,564,973 $0 +$60,564,973 KMTS, CBLL, ALMS, CGON, CRGX 13F-HR 15 May 2025, 11:16
Q4 2024 7 $51,953,198 +$31,630,588 $0 +$31,630,588 CBLL, CRGX, ALMS, CSTL, SGMT 13F-HR 14 Feb 2025, 09:41
Q3 2024 6 $32,481,259 $0 -$53,789,964 -$53,789,964 CRGX, ALMS, CGON, CSTL, PYXS 13F-HR 14 Nov 2024, 07:30
Q2 2024 6 $76,530,244 +$76,105,261 -$71,930,309 +$4,174,952 CGON, CRGX, ALMS, CSTL, PYXS 13F-HR 14 Aug 2024, 08:01
Q1 2024 5 $72,535,510 +$71,930,309 -$19,518,874 +$52,411,435 PRE, AGLE, SONX, SGMT, PYXS 13F-HR 15 May 2024, 07:00
Q4 2023 4 $19,953,589 +$19,518,874 -$768,580 +$18,750,294 CRGX, CSTL, SGMT, PYXS 13F-HR 14 Feb 2024, 07:26
Q3 2023 5 $1,409,764 +$641,184 -$1,999,817 -$1,358,633 SGMT, SONX, AGLE, PYXS, PRE 13F-HR 14 Nov 2023, 15:44
Q2 2023 5 $1,274,878 $0 $0 $0 SONX, CSTL, APGN, AGLE, PRE 13F-HR 14 Aug 2023, 16:09
Q1 2023 5 $1,815,889 $0 -$5,058,117 -$5,058,117 SONX, CSTL, APGN, AGLE, PRE 13F-HR 15 May 2023, 11:20
Q4 2022 6 $7,467,955 $0 $0 $0 ABGI, SONX, CSTL, APGN, AGLE 13F-HR 14 Feb 2023, 10:23
Q3 2022 6 $7,340,000 +$1,085,000 $0 +$1,085,000 ABGI, APGN, SONX, CSTL, PRE 13F-HR 14 Nov 2022, 07:41
Q2 2022 5 $6,465,000 +$553,000 -$22,000 +$531,000 ABGI, SONX, CSTL, PRE, AGLE 13F-HR 15 Aug 2022, 09:40
Q1 2022 4 $7,395,000 $0 $0 $0 ABGI, SONX, AGLE, DIFFUSION PHARMACEUTICALS IN 13F-HR 16 May 2022, 06:54
Q4 2021 4 $8,618,000 +$3,156,000 $0 +$3,156,000 ABGI, SONX, AGLE, DIFFUSION PHARMACEUTICALS IN 13F-HR 14 Feb 2022, 07:41
Q3 2021 3 $5,820,000 $0 -$3,090,000 -$3,090,000 ABGI, AGLE, DIFFUSION PHARMACEUTICALS IN 13F-HR 15 Nov 2021, 07:12
Q2 2021 4 $8,849,000 $0 -$17,214,451 -$17,214,451 ABGI, AVIR, AGLE, DIFFUSION PHARMACEUTICALS IN Restatement 17 Sep 2021, 15:08
Q1 2021 5 $38,313,000 +$4,958,000 $0 +$4,958,000 AVIR, LUNG, ABGI, AGLE, DIFFUSION PHARMACEUTICALS IN Restatement 17 Sep 2021, 15:08
Q4 2020 1 $0 $0 $0 $0 New Holdings 17 May 2021, 07:29
Q4 2020 3 $13,487,000 $0 $0 $0 AVIR, AGLE, DIFFUSION PHARMACEUTICALS IN 13F-HR 16 Feb 2021, 07:17